{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:06:45Z","timestamp":1780445205499,"version":"3.54.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04596-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:43:57Z","timestamp":1749113037000},"page":"3477-3478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reassessing finerenone\u2019s role in IgA nephropathy: methodological and clinical considerations"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9071-1505","authenticated-orcid":false,"given":"Muhammad","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syyeda","family":"Nargis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"4596_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04512-3","author":"Q Gao","year":"2025","unstructured":"Gao Q, Lin H, Zhao Z, Peng S, Wu Q, Dong X et al (2025) Effectiveness and safety of finerenone in the treatment of IgA Nephrology patients: a retrospective, real-world study. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-025-04512-3","journal-title":"Int Urol Nephrol"},{"key":"4596_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/026921559701100402","author":"PC Siemonsma","year":"1997","unstructured":"Siemonsma PC, Walker MF (1997) Practical guidelines for independent assessment in randomized controlled trials (RCTs) of rehabilitation. Clin Rehabil. https:\/\/doi.org\/10.1177\/026921559701100402","journal-title":"Clin Rehabil"},{"key":"4596_CR3","doi-asserted-by":"crossref","unstructured":"Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder RE, Anker SD, et al. Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes. J Hypertens [Internet]. 2023 Feb 1 [cited 2025 May 3];41(2):295\u2013302. https:\/\/journals.lww.com\/jhypertension\/fulltext\/2023\/02000\/effect_of_finerenone_on_ambulatory_blood_pressure.12.aspx","DOI":"10.1097\/HJH.0000000000003330"},{"key":"4596_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03685-z","author":"N Saleem","year":"2024","unstructured":"Saleem N, Nasir H, Anwar F, Aziz M, Khurshid K, Bashir S et al (2024) To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-023-03685-z","journal-title":"Int Urol Nephrol"},{"key":"4596_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-022-2561-y","author":"MK Das","year":"2022","unstructured":"Das MK (2022) Multicenter studies: relevance, design and implementation. Indian Pediatr. https:\/\/doi.org\/10.1007\/s13312-022-2561-y","journal-title":"Indian Pediatr"},{"key":"4596_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P et al (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2110956","journal-title":"N Engl J Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04596-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:59:54Z","timestamp":1758808794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04596-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":6,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4596"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04596-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}